-
公开(公告)号:US20100183710A1
公开(公告)日:2010-07-22
申请号:US11994943
申请日:2006-07-07
申请人: Vijayabhaskar Bolugoddu , Jaydeepkumar Dahyabhai Lilakar , Ramchandra Reddy Pingili , Swarupa Reddy Dudipala , Adolf Ceasor Goldwyn , Bala Murali Krishna Pittala , Mailatur Sivaraman Mohan , Indu Bhushan , Ravinder Kodipyaka , Rahul Sudhakar Gawande , Srikanth Basety
发明人: Vijayabhaskar Bolugoddu , Jaydeepkumar Dahyabhai Lilakar , Ramchandra Reddy Pingili , Swarupa Reddy Dudipala , Adolf Ceasor Goldwyn , Bala Murali Krishna Pittala , Mailatur Sivaraman Mohan , Indu Bhushan , Ravinder Kodipyaka , Rahul Sudhakar Gawande , Srikanth Basety
IPC分类号: A61K9/64 , C07D401/12 , A61K31/4439 , A61K9/16
CPC分类号: C07D401/12
摘要: A process for preparing pure omeprazole Form B, and compositions containing omeprazole Form B.
摘要翻译: 制备纯奥美拉唑B型的组合物和含奥美拉唑B型的组合物。
-
2.SOLUBILITY-ENHANCED PHARMACEUTICAL COMPOSITIONS COMPRISING ZAFIRLUKAST 审中-公开
标题翻译: 包含ZAFIRLUKAST的溶解性增强药物组合物公开(公告)号:US20090012146A1
公开(公告)日:2009-01-08
申请号:US12166493
申请日:2008-07-02
申请人: Giridhar Reddy Buggana , Srikanth Basety , Rahul Sudhakar Gawande , Ravinder Kodipyaka , Srinivas Irukulla , Indu Bhushan , Mailatur Sivaraman Mohan , Praveen Kumar Bembaloor
发明人: Giridhar Reddy Buggana , Srikanth Basety , Rahul Sudhakar Gawande , Ravinder Kodipyaka , Srinivas Irukulla , Indu Bhushan , Mailatur Sivaraman Mohan , Praveen Kumar Bembaloor
IPC分类号: A61K31/404 , A61P11/06
CPC分类号: A61K9/146 , A61K9/145 , A61K9/1623 , A61K9/1652
摘要: Stable pharmaceutical compositions comprising zafirlukast and pharmaceutically acceptable salts, solvates, polymorphs, enantiomers or mixtures thereof, together with one or more pharmaceutically acceptable polymers, and processes for their preparation.
摘要翻译: 包含扎非司酮及其药学上可接受的盐,溶剂化物,多晶型物,对映体或其混合物以及一种或多种药学上可接受的聚合物的稳定的药物组合物,及其制备方法。
-
公开(公告)号:US20080167325A1
公开(公告)日:2008-07-10
申请号:US11963946
申请日:2007-12-24
IPC分类号: A61K31/522 , C07D473/30 , A61P31/12
CPC分类号: A61K31/522 , A61K9/2009 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K9/48
摘要: Solid pharmaceutical compositions of valacyclovir or pharmaceutically acceptable salts thereof. Embodiments of the invention relate to processes for preparing solid pharmaceutical compositions, avoiding a wet granulation step.
摘要翻译: 伐昔洛韦的固体药物组合物或其药学上可接受的盐。 本发明的实施方案涉及制备固体药物组合物的方法,避免湿法制粒步骤。
-
公开(公告)号:US20100129310A1
公开(公告)日:2010-05-27
申请号:US11573505
申请日:2005-08-08
申请人: Pavak Rajnikanth Mehta , Indu Bushan , Vijay Dinanathji Nasare , Mailatur Sivaraman Mohan , Rahul Sudhakar Gawande , Ravinder Kodipyaka
发明人: Pavak Rajnikanth Mehta , Indu Bushan , Vijay Dinanathji Nasare , Mailatur Sivaraman Mohan , Rahul Sudhakar Gawande , Ravinder Kodipyaka
IPC分类号: A61K31/444 , B01J41/12
CPC分类号: A61K31/473
摘要: Stabilized desloratadine-containing pharmaceutical compositions are prepared using complexes formed by combining desloratadine and a resin in the acidic form.
摘要翻译: 使用通过组合地氯雷他定和酸性形式的树脂形成的络合物来制备含有去氯雷他定的药物组合物。
-
公开(公告)号:US20090124657A1
公开(公告)日:2009-05-14
申请号:US12191611
申请日:2008-08-14
申请人: Ramesh Kappala , Basety Srikanth , Rahul Sudhakar Gawande , Subhash Pandurang Gore , Irukulla Srinivas , Indu Bhushan , Mailatur Sivaraman Mohan
发明人: Ramesh Kappala , Basety Srikanth , Rahul Sudhakar Gawande , Subhash Pandurang Gore , Irukulla Srinivas , Indu Bhushan , Mailatur Sivaraman Mohan
CPC分类号: A61K9/2018 , A61K9/0056
摘要: Pharmaceutical compositions comprising montelukast or pharmaceutically acceptable salts, solvates, polymorphs, enantiomers or mixtures thereof.
摘要翻译: 包含孟鲁司特或其药学上可接受的盐,溶剂合物,多晶型物,对映体或其混合物的药物组合物。
-
公开(公告)号:US20110189271A1
公开(公告)日:2011-08-04
申请号:US13018483
申请日:2011-02-01
申请人: Vishal Lad , Ajmal MD Shareef , Vinay Muley , Sushant Dube , Ashwini Rewatkar , Rahul Sudhakar Gawande , Srinivas Irukulla , Surakumar Jayanthi
发明人: Vishal Lad , Ajmal MD Shareef , Vinay Muley , Sushant Dube , Ashwini Rewatkar , Rahul Sudhakar Gawande , Srinivas Irukulla , Surakumar Jayanthi
CPC分类号: A61K9/00 , A61K9/14 , A61K9/20 , A61K9/48 , A61K31/4439
摘要: Pharmaceutical formulations comprising inert cores that are coated with a layer comprising an amorphous dexlansoprazole sodium salt formed in-situ, further sequentially coated with an intermediate layer and an enteric coating layer. Coated cores may be further formulated to produce tablets or capsules.
摘要翻译: 包含惰性核的药物制剂,其涂覆有包含原位形成的无定形右兰索拉唑钠盐的层,并进一步依次涂覆有中间层和肠溶衣层。 可以进一步配制涂覆的芯以产生片剂或胶囊。
-
7.PHARMACEUTICAL FORMULATIONS COMPRISING SUBSTITUTED BENZIMIDAZOLE DERIVATIVES 审中-公开
标题翻译: 包含取代苯并咪唑衍生物的药物制剂公开(公告)号:US20120058194A1
公开(公告)日:2012-03-08
申请号:US13217901
申请日:2011-08-25
申请人: Navin Vaya , Mamta Mishra , Atul Shivaji Shinde , Harshal Prabhakar Bhagwatwar , Debashis Dash , Deepti Jain , Rahul Sudhakar Gawande , Vishal Lad , Sushant Dube , Venkateswarlu Vobalaboina , Srinivas Irukulla , Manikandan Ramalingam
发明人: Navin Vaya , Mamta Mishra , Atul Shivaji Shinde , Harshal Prabhakar Bhagwatwar , Debashis Dash , Deepti Jain , Rahul Sudhakar Gawande , Vishal Lad , Sushant Dube , Venkateswarlu Vobalaboina , Srinivas Irukulla , Manikandan Ramalingam
IPC分类号: A61K9/14 , A61K47/38 , B05D5/00 , A61K47/44 , A61K31/4439 , A61P1/04 , A61K47/36 , A61K47/46
CPC分类号: A61K31/4439 , A61K9/2081 , A61K9/5026 , A61K9/5047 , A61K9/5078 , A61K9/5084
摘要: Stabilized substituted benzimidazole modified release pharmaceutical formulations with at least two drug-containing fractions, wherein the release from a first fraction precedes the release from a second fraction, pharmaceutical excipients, processes for preparing the stable formulations, packaging therefor, and their use in treatment of erosive esophagitis and heartburn associated with non-erosive gastroesophageal reflux disease.
摘要翻译: 具有至少两种含药物级分的稳定取代的苯并咪唑改性释放药物制剂,其中来自第一级分的释放先于来自第二级分的释放,药物赋形剂,用于制备稳定制剂的方法,其包装及其在治疗中的用途 侵蚀性食道炎和胃灼热与非侵蚀性胃食管反流病有关。
-
-
-
-
-
-